Speaking today at the White Rose Bioscience Forum in York (Tuesday 31 October), Wallder told delegates:
“For early stage life science companies, building a successful management team is the ‘holy grail’. The best management can make ordinary technology fly, but poor management will very often result in companies with even the best technology either not achieving their full potential – or worse, failing miserably!”
Today's life science executives need a broader range of skills and competencies than ever before: raising funds, managing complex intellectual property and licensing issues and not least leading and managing their staff - all whilst aiming for realistic exit strategies for investors.
“Building successful management teams is about hiring the right people at the right time,” Wallder says. ”A great start-up CEO will not necessarily be the right person at the series B investment stage, or at trade sale or IPO.”
Wallder advises that the UK should try to emulate the US, where life science companies take a different view to management: “In the US, the mindset is different”, he explains. “It’s recognised that the skill set required throughout a company’s life will be different at specific stages, and because there are so few people with the necessary skills and experience to drive a company from start-up to plc, it is common practice for senior management to be replaced during the company’s progression.”
However, in the US this is not viewed as failure on the part of the outgoing management – it’s simply a pragmatic step that ensures the continued commercial health of the company. Says Wallder: “The management is seen as having effectively completed the job they were hired to do at that particular stage. The beauty of the US practice is that it frees up talented executives for other companies, who are at the stage where they could use their particular skills and experience.”
In the UK, the perception of success and failure is different, he says, an outgoing senior management can be seen in a negative light, rather than congratulated for successfully taking the company to its next stage.
“The UK practice of hiring a CEO and then expecting that person to be all things to all people at all stages is unrealistic. This is particularly so when the founding academic takes on the CEO role. It is the responsibility of the company board and its investors to allow senior management to play to their strengths but to recognise when new strengths are required. The company will be more attractive to investors in later funding rounds if this issue is addressed before approaches for funding are made,” he says.
Jo Kelly | alfa
Flow of cerebrospinal fluid regulates neural stem cell division
21.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Chemists at FAU successfully demonstrate imine hydrogenation with inexpensive main group metal
21.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology